Inspire Medical Systems (INSP) Fundamentals 2026 — P/E 11.3x, Revenue Analysis | SniperIQ
Inspire Medical Systems (INSP) is a US-listed Healthcare company in Medical - Devices with a market capitalization of
.5B, trading at $51.18 on the NYSE. This SniperIQ fundamentals page covers Inspire Medical Systems's valuation (P/E 11.3x, P/B 1.9x), profitability (net margin 14.3%), revenue ($912M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Market Cap
.5B
P/E (TTM)11.3x
Net Margin14.3%
Revenue (FY25)$912M
Full research coverage
8-Quarter Revenue & Margin Trend
Debt Maturity & Coverage
Peer Valuation Comparison
Free Cash Flow & Owner Earnings
AI Signal + Institutional Flow
DCF Valuation Model
Frequently Asked Questions
What is Inspire Medical Systems's market cap?
Inspire Medical Systems (INSP) has a market capitalization of approximately
.5B, trading at $51.18 on the NYSE. Market cap moves with the live share price.
What is Inspire Medical Systems's P/E ratio?
Inspire Medical Systems's trailing twelve-month P/E ratio is 11.3x, with a price-to-book (P/B) of 1.9x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Inspire Medical Systems?
Inspire Medical Systems runs a net profit margin of 14.3%, a gross margin of 85.8%, and an operating margin of 5.6%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Inspire Medical Systems generate?
Inspire Medical Systems reported revenue of $912M for fiscal year 2025, with net income of
45M and earnings per share (EPS) of 4.95. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Inspire Medical Systems pay a dividend?
Inspire Medical Systems does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is Inspire Medical Systems financially healthy?
Inspire Medical Systems carries a debt-to-equity ratio of 0.04x and a current ratio of 6.34x, with a market beta of 0.71. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Inspire Medical Systems a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Inspire Medical Systems (INSP) the key facts are: market cap
.5B, P/E 11.3x, revenue $912M, 52-week range 38.91-147.03. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Inspire Medical Systems's full fundamentals live
Get Inspire Medical Systems's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.